MetLife Investment Management’s Northrop Grumman NOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.6M | Sell |
30,548
-631
| -2% | -$364K | 0.07% | 266 |
|
|
2026
Q1 | $21.3M | Sell |
31,179
-1,008
| -3% | -$697K | 0.11% | 154 |
|
|
2025
Q4 | $18.4M | Sell |
32,187
-1,228
| -4% | -$713K | 0.09% | 189 |
|
|
2025
Q3 | $20.4M | Sell |
33,415
-1,064
| -3% | -$603K | 0.1% | 161 |
|
|
2025
Q2 | $17.2M | Sell |
34,479
-873
| -2% | -$429K | 0.1% | 183 |
|
|
2025
Q1 | $18.1M | Sell |
35,352
-917
| -3% | -$438K | 0.1% | 176 |
|
|
2024
Q4 | $17M | Buy |
36,269
+513
| +1% | +$258K | 0.09% | 161 |
|
|
2024
Q3 | $18.9M | Sell |
35,756
-1,359
| -4% | -$665K | 0.11% | 146 |
|
|
2024
Q2 | $16.2M | Buy |
37,115
+3,750
| +11% | +$1.71M | 0.1% | 159 |
|
|
2024
Q1 | $16M | Sell |
33,365
-1,410
| -4% | -$649K | 0.11% | 149 |
|
|
2023
Q4 | $16.3M | Sell |
34,775
-762
| -2% | -$357K | 0.12% | 135 |
|
|
2023
Q3 | $15.6M | Sell |
35,537
-1,044
| -3% | -$458K | 0.12% | 132 |
|
|
2023
Q2 | $16.7M | Sell |
36,581
-1,229
| -3% | -$558K | 0.12% | 134 |
|
|
2023
Q1 | $17.5M | Sell |
37,810
-695
| -2% | -$323K | 0.13% | 126 |
|
|
2022
Q4 | $21M | Sell |
38,505
-830
| -2% | -$433K | 0.16% | 107 |
|
|
2022
Q3 | $18.5M | Sell |
39,335
-738
| -2% | -$352K | 0.15% | 112 |
|
|
2022
Q2 | $19.2M | Sell |
40,073
-416
| -1% | -$191K | 0.15% | 113 |
|
|
2022
Q1 | $18.1M | Buy |
40,489
+7,563
| +23% | +$3.12M | 0.12% | 139 |
|
|
2021
Q4 | $12.7M | Sell |
32,926
-1,067
| -3% | -$397K | 0.1% | 153 |
|
|
2021
Q3 | $12.2M | Sell |
33,993
-713
| -2% | -$258K | 0.11% | 149 |
|
|
2021
Q2 | $12.6M | Sell |
34,706
-2,242
| -6% | -$807K | 0.11% | 151 |
|
|
2021
Q1 | $12M | Sell |
36,948
-706
| -2% | -$213K | 0.11% | 155 |
|
|
2020
Q4 | $11.5M | Sell |
37,654
-1,657
| -4% | -$507K | 0.11% | 155 |
|
|
2020
Q3 | $12.4M | Sell |
39,311
-1,237
| -3% | -$403K | 0.14% | 140 |
|
|
2020
Q2 | $12.5M | Buy |
40,548
+147
| +0.4% | +$48.2K | 0.14% | 136 |
|
|
2020
Q1 | $12.2M | Sell |
40,401
-1,236
| -3% | -$430K | 0.17% | 113 |
|
|
2019
Q4 | $14.3M | Sell |
41,637
-1,185
| -3% | -$417K | 0.15% | 128 |
|
|
2019
Q3 | $16M | Sell |
42,822
-3,982
| -9% | -$1.41M | 0.18% | 109 |
|
|
2019
Q2 | $15.1M | Sell |
46,804
-97,898
| -68% | -$29.2M | 0.16% | 114 |
|
|
2019
Q1 | $39M | Buy |
144,702
+95,065
| +192% | +$25.9M | 0.12% | 132 |
|
|
2018
Q4 | $12.2M | Sell |
49,637
-1,000
| -2% | -$276K | 0.15% | 129 |
|
|
2018
Q3 | $16.1M | Sell |
50,637
-698
| -1% | -$213K | 0.16% | 113 |
|
|
2018
Q2 | $15.8M | Sell |
51,335
-1,053
| -2% | -$348K | 0.19% | 101 |
|
|
2018
Q1 | $18.3M | Sell |
52,388
-1,474
| -3% | -$494K | 0.22% | 87 |
|
|
2017
Q4 | $16.5M | Buy |
+53,862
| New | +$16.2M | 0.19% | 102 |
|
Other funds holding NOC
MetLife Investment Management's NOC Position: Q2 2026 in Review
MetLife Investment Management reduced its Northrop Grumman (NOC) stake by 2% in Q2 2026, selling an estimated $364K and leaving 30,548 shares worth $15.6M. The position accounts for 0.07% of the portfolio, ranked #266.
MetLife Investment Management first reported a position in NOC in Q4 2017 and has held it in 35 quarters since. The position peaked at $39M in Q1 2019. 1,817 funds tracked by Wall St. Rank hold NOC as of Q2 2026.
- MetLife Investment Management held 30,548 shares of Northrop Grumman worth $15.6M as of Q2 2026.
- MetLife Investment Management sold 631 Northrop Grumman shares in Q2 2026, an estimated $364K.
- Northrop Grumman made up 0.07% of MetLife Investment Management's portfolio in Q2 2026, its #266 holding.
- MetLife Investment Management first reported a position in Northrop Grumman in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Northrop Grumman position peaked at $39M in Q1 2019.
- 1,817 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.